TABLE 2.
| Local Progression | |||||
|---|---|---|---|---|---|
| Total | Yes | No | |||
|
| |||||
| n | n | (%) | n | (%) | |
| Radiation Sensitive | 42 | 9 | (21.4) | 26 | (61.9) |
|
| |||||
| Breast | 11 | 1 | (9.1) | 9 | (81.8) |
|
| |||||
| Prostate | 24 | 7 | (29.2) | 12 | (50.0) |
|
| |||||
| Other | 7 | 1 | (16.7) | 5 | (83.3) |
|
| |||||
| Radiation Resistant | 144 | 25 | (17.4) | 103 | (71.5) |
|
| |||||
| Colorectal | 15 | 1 | (6.7) | 10 | (66.7) |
|
| |||||
| Hepatocellular | 6 | 1 | (16.7) | 4 | (66.7) |
|
| |||||
| Lung, non-small cell | 15 | 3 | (20.0) | 10 | (66.7) |
|
| |||||
| Melanoma | 9 | 0 | (0) | 9 | (100) |
|
| |||||
| Renal cell | 41 | 8 | (19.5) | 31 | (75.6) |
|
| |||||
| Sarcoma | 33 | 7 | (21.2) | 25 | (75.8) |
|
| |||||
| Squamous cell | 3 | 1 | (33.3) | 2 | (66.7) |
|
| |||||
| Thyroid | 5 | 2 | (40.0) | 3 | (60.0) |
|
| |||||
| Other | 17 | 2 | (11.8) | 11 | (64.7) |